The Impact of Sleep Disturbance on Gut Microbiota, Atrial Substrate, and Atrial Fibrillation Inducibility in Mice: A Multi-Omics Analysis.
Kun ZuoChen FangYuan FuZheng LiuYe LiuLifeng LiuYuxing WangHongjiang WangXiandong YinXiaoqing LiuJing LiJiuchang ZhongMulei ChenXinchun YangLi XuPublished in: Metabolites (2022)
This study examined the effect of sleep disturbance on gut microbiota (GM), atrial substrate, and atrial fibrillation (AF) inducibility. C57BL/6 mice were subjected to six weeks of sleep deprivation (SD) using the method of modified multiple-platform. Transesophageal burst pacing was performed to evaluate AF inducibility. Feces, plasma, and an atrium were collected and analyzed by 16s rRNA sequencing, liquid chromatography-mass spectrometry (LC-MS)-based metabolome, histological studies, and transcriptome. Higher AF inducibility (2/30 of control vs. 15/30 of SD, p = 0.001) and longer AF duration ( p < 0.001), concomitant with aggravated fibrosis, collagen, and lipid accumulation, were seen in the SD mice compared to control mice. Meanwhile, elevated alpha diversity, higher abundance of Flavonifractor , Ruminococcus, and Alloprevotella , as well as imbalanced functional pathways, were observed in the gut of SD mice. Moreover, the global patterns for the plasma metabolome were altered, e.g., the decreased butanoate metabolism intermediates in SD mice. In addition, disrupted metabolic homeostasis in the SD atrium, such as fatty acid metabolism, was analyzed by the transcriptome. These results demonstrated that the crosstalk between GM and atrial metabolism might be a promising target for SD-mediated AF susceptibility.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial appendage
- high fat diet induced
- left atrial
- mass spectrometry
- liquid chromatography
- oral anticoagulants
- single cell
- direct oral anticoagulants
- wild type
- heart failure
- physical activity
- fatty acid
- adipose tissue
- type diabetes
- genome wide
- percutaneous coronary intervention
- insulin resistance
- coronary artery disease
- acute coronary syndrome
- pulmonary hypertension
- venous thromboembolism
- microbial community
- wastewater treatment
- inferior vena cava
- liver fibrosis
- high resolution mass spectrometry